home / stock / kpti / kpti news

KPTI News and Press, Karyopharm Therapeutics Inc. From 03/09/22

Stock Information
Company Name: Karyopharm Therapeutics Inc.
Stock Symbol: KPTI
Market: NASDAQ
Website: karyopharm.com
Menu
KPTI KPTI Quote KPTI Short KPTI News KPTI Articles KPTI Message Board
Get KPTI Alerts

News, Short Squeeze, Breakout and More Instantly...
KPTI - Karyopharm to Participate at the Barclays Global Healthcare Conference

Karyopharm to Participate at the Barclays Global Healthcare Conference PR Newswire NEWTON, Mass. , March 9, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
KPTI - ZNGA, KPTI and PBYI among after hour movers

Gainers: Funko FNKO +16%. Puma Biotechnology PBYI +15%. Duolingo DUOL +15%. Alignment Healthcare ALHC +11%. Veritone VERI +8%. Losers: Smith & Wesson Brands SWBI -15%. Moderna MRNA -6%. Payoneer Global  PAYO -4%. Karyopharm Therapeuti...

KPTI - Organogenesis, CytomX top healthcare gainers; Karyopharm Bright Health lead losers' pack

Gainers: Organogenesis (NASDAQ:ORGO) +24%. CytomX Therapeutics (NASDAQ:CTMX) +13%. X4 Pharmaceuticals (NASDAQ:XFOR) +13%. MannKind (NASDAQ:MNKD) +10%. Allied Healthcare (NASDAQ:AHPI) +6%. Losers: Karyopharm Therapeutics (NASDAQ:KPTI) -31%. Bright Health Grou...

KPTI - Karyopharm sinks on setback for U.S. label expansion of cancer therapy

The shares of the commercial-stage pharmaceutical company, Karyopharm Therapeutics (NASDAQ:KPTI) have lost ~28% in the pre-market Wednesday amid concerns that the company will need another trial to support its request for U.S. label expansion of cancer therapy, Xpovio (selinexor). F...
KPTI - ZIMV, KPTI and HOOK among after hour movers

Gainers: SoFi Technologies SOFI +20%. Scientific Games Corp SGMS +10%. CytomX Therapeutics CTMX +10%. ZimVie  (ZIMV) +9%. PLBY Group PLBY +9%. Losers: Karyopharm Therapeutics  (NASDAQ:KPTI) -27%. HOOKIPA Pharma  HOOK -20%. Proterra PTRA -...

KPTI - Karyopharm Provides U.S. Regulatory Update on Selinexor in Advanced or Recurrent Endometrial Cancer

Karyopharm Provides U.S. Regulatory Update on Selinexor in Advanced or Recurrent Endometrial Cancer Following Discussion with the FDA, Karyopharm Plans to Initiate a New Placebo-Controlled Randomized Study of Selinexor in the Advanced or Recurrent Endometrial Cancer p53 Wild-Typ...

KPTI - Here's Why Karyopharm Therapeutics Is Sliding on Tuesday

Shares of Karyopharm Therapeutics (NASDAQ: KPTI) , a biopharmaceutical company developing new cancer drugs, are tanking Tuesday as investors respond to an unexpected leadership change. The stock was trading 30.5% lower as of 11:52 a.m. ET. On Feb. 8, shares of Karyopharm s...
KPTI - IRNT, FAT and DTSS among mid-day movers

Gainers: Indonesia (NYSE:INDO) +79%. Meritor (NYSE:MTOR) +45%. Ocugen (NASDAQ:OCGN) +22%. Datasea (NASDAQ:DTSS) +20%. IronNet (NYSE:IRNT) +20%. Riley Exploration Permian (NYSE:REPX) +19%. Arteris (NASDAQ:AIP) +17%. Houghton Mifflin Harcourt Company (NASDAQ:HMHC) +15%. MEDIROM Healthcare Techn...

KPTI - HOOKIPA, Nuvectis top healthcare gainers; Allarity, Homology Medicines lead losers' pack

Gainers: HOOKIPA Pharma HOOK +18%. Nuvectis Pharma (NASDAQ:NVCT) +16%. Ocugen OCGN +14%. Privia Health (NASDAQ:PRVA) +12%. IMARA (NASDAQ:IMRA) +11%. Losers: Allarity Therapeutics (NASDAQ:ALLR) -29%. Homology Medicines FIXX -27%. Karyopharm The...

KPTI - Yandex, Bilibili, Mobile TeleSystems among premarket losers' pack

Homology Medicines (NASDAQ:FIXX) -25% on FDA clinical hold for phenylketonuria trial. Karyopharm Therapeutics (NASDAQ:KPTI) -23% as medical chief steps down. Inspirato (NASDAQ:ISPO) -17%. QIWI (NASDAQ:QIWI) -14%. Yandex (NASDAQ:YNDX) -13%. Energy Vault (NYSE:NRGV) -12%. Ar...
Previous 10 Next 10